The Montpellier Neuroscience Community comprises researchers, research-professors, and clinical practitioners working at Montpellier and Nîmes CHUs with 30 research teams in 6 research institutes (CRBM, IGF, IGH, IGMM, INM, MMDN).
The community includes two Aviesan certified Excellence Centers. The Montpellier Excellence Center for Neurodegenerative Diseases – “CoEN” – focuses on promoting biomarkers and personalized medicine. The center’s goal is to foster the emergence of multidisciplinary projects that bring fundamental, preclinical, clinical, and epidemiological research together with social sciences covering diseases representing major public health issues such as Alzheimer’s and Parkinson’s diseases, as well as multiple sclerosis and ALS. The other entity is the Excellence Center for Autism – “CeAND” – whose goal is to boost translational research on Autism Spectrum Disorder (ASD) and the discovery of biomarkers for a common pathology for which clinical diagnosis is sometimes difficult to establish.
The neuroscience community also benefits from the FHU NEUROCLIN Hospital-University Federation, whose goal is to provide structure for neuroscience research in fields where regional expertise is strong (sensormotor pathologies, neurodegeneration, cognition, psychiatry), leading up to clinical trials and the creation of companies to develop new drugs and technological devices.
These excellence centers also leverage their synergy, particularly by sharing
multicentric cohorts, certified biobanks, and cutting-edge technology approaches such as next-generation sequencing (NGS), quantitative mass spectrometry, and ultrasensitive multiplex immunodetection.